The first stop for professional medicines advice

Guidance

664 results

Applied filters

Treating urinary disorders during breastfeeding

21 March 2023Oxybutynin is preferred for urinary disorders during breastfeeding. Recommendations apply to full term and healthy infants only.

Accredited training for pharmacy staff within technical services

17 March 2023Pharmacy staff involved in the preparation of aseptically-prepared products should be suitably trained and accredited to assure a safe service

Using amlodipine or MR felodipine for angina and hypertension

13 March 2023Guidance on choosing and switching between amlodipine and modified-release (MR) felodipine for angina and hypertension.

Managing the risks of using effervescent tablets in children

9 March 2023Careful use of effervescent or soluble tablets to deliver part tablet doses for children and neonates can minimise risks of toxicity or suboptimal therapy.

Understanding the falsified medicines directive

9 March 2023An overview of the changes to the requirements for medicines ‘safety features’ following the UK’s departure from the EU

Pharmacy Manual Checklist for Clinical Trials for ATIMPs

2 March 2023Pharmacy Manual content expectations for optimal site implementation of ATIMP Clinical Trials.

Accessing the CAR-T training passport for clinical pharmacists

28 February 2023The Pan UK Pharmacy Working Group for ATMPs has collaborated with UK BMT (Bone Marrow Transplant) pharmacists to produce a CAR-T verification passport

Using folic acid with methotrexate in rheumatoid arthritis

20 February 2023Folic acid is used to reduce methotrexate associated adverse effects in people with rheumatoid arthritis. This page guides appropriate dosing.

MAOI to other antidepressants: switching in adults

17 February 2023Switching between or from a monoamine oxidase inhibitor (MAOI) is a complex switch and requires support from a specialist. General principles are described.

Moclobemide to other antidepressants: switching in adults

17 February 2023Suggested methods for switching safely from moclobemide to other antidepressants. Switches requiring additional specialist support are highlighted.
admin